Search Results - "Baid, Rinku"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease by Cruz, Nelly M, Yuan, Yang, Leehy, Barrett D, Baid, Rinku, Kompella, Uday, DeAngelis, Margaret M, Escher, Pascal, Haider, Neena B

    Published in PloS one (31-01-2014)
    “…Nuclear hormone receptors play a major role in many important biological processes. Most nuclear hormone receptors are ubiquitously expressed and regulate…”
    Get full text
    Journal Article
  2. 2

    LEDGF(1-326) decreases P23H and wild type rhodopsin aggregates and P23H rhodopsin mediated cell damage in human retinal pigment epithelial cells by Baid, Rinku, Scheinman, Robert I, Shinohara, Toshimichi, Singh, Dhirendra P, Kompella, Uday B

    Published in PloS one (2011)
    “…P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE) cells are…”
    Get full text
    Journal Article
  3. 3

    Investigating thiol‐modification on hyaluronan via carbodiimide chemistry using response surface methodology by Santhanam, Sruthi, Liang, Jue, Baid, Rinku, Ravi, Nathan

    “…Hyaluronan (HA) is a naturally occurring glycosaminoglycan widely researched for its use as a biomaterial in tissue engineering, drug delivery, angiogenesis,…”
    Get full text
    Journal Article
  4. 4

    Critical considerations for developing nucleic acid macromolecule based drug products by Muralidhara, Bilikallahalli K., Baid, Rinku, Bishop, Steve M., Huang, Min, Wang, Wei, Nema, Sandeep

    Published in Drug discovery today (01-03-2016)
    “…•Increased emphasis in recent years on DNA/mRNA macromolecule-based therapeutic drugs.•Formulation excipients and their role in increasing the drug product…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Critical considerations for developing nucleic acid macromolecule based drug products: Foundation by Muralidhara, Bilikallahalli K, Baid, Rinku, Bishop, Steve M, Huang, Min, Wang, Wei, Nema, Sandeep

    Published in Drug discovery today (01-03-2016)
    “…Protein expression therapy using nucleic acid macromolecules (NAMs) as a new paradigm in medicine has recently gained immense therapeutic potential. With the…”
    Get full text
    Journal Article
  8. 8

    Biosynthesis, Characterization, and Efficacy in Retinal Degenerative Diseases of Lens Epithelium-derived Growth Factor Fragment (LEDGF1–326), a Novel Therapeutic Protein by Baid, Rinku, Upadhyay, Arun K., Shinohara, Toshimichi, Kompella, Uday B.

    Published in The Journal of biological chemistry (14-06-2013)
    “…For vision-threatening retinitis pigmentosa and dry age-related macular degeneration, there are no United States Food and Drug Administration (FDA)-approved…”
    Get full text
    Journal Article
  9. 9

    Modifier Genes as Therapeutics: The Nuclear Hormone Receptor Rev Erb Alpha by Cruz, Nelly M, Yuan, Yang, Leehy, Barrett D, Baid, Rinku, Kompella, Uday, DeAngelis, Margaret M, Escher, Pascal, Haider, Neena B

    Published in PloS one (31-01-2014)
    “…Nuclear hormone receptors play a major role in many important biological processes. Most nuclear hormone receptors are ubiquitously expressed and regulate…”
    Get full text
    Journal Article
  10. 10

    LEDGF.sub.1-326 Decreases P23H and Wild Type Rhodopsin Aggregates and P23H Rhodopsin Mediated Cell Damage in Human Retinal Pigment Epithelial Cells by Baid, Rinku, Scheinman, Robert I, Shinohara, Toshimichi, Singh, Dhirendra P, Kompella, Uday B

    Published in PloS one (07-09-2011)
    “…Background P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE)…”
    Get full text
    Journal Article
  11. 11

    Lens epithelium derived growth factor (1-326): A new protein drug for retinal diseases by Baid, Rinku

    Published 01-01-2013
    “…Although over 2.2 million people in the United States suffer from dry age related macular degeneration and retinitis pigmentosa, there are no FDA approved…”
    Get full text
    Dissertation
  12. 12

    LEDGF1-326 Decreases P23H and Wild Type Rhodopsin Aggregates and P23H Rhodopsin Mediated Cell Damage in Human Retinal Pigment Epithelial Cells by Baid, Rinku, Scheinman, Robert I., Shinohara, Toshimichi, Singh, Dhirendra P., Kompella, Uday B.

    Published in PloS one (07-09-2011)
    “…Background P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE)…”
    Get full text
    Journal Article